|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
DK1635875T3
(da)
|
2003-06-26 |
2009-01-12 |
Psivida Inc |
In-situ-geldannende lægemiddeladministrationssystem
|
|
CA2553254C
(en)
|
2004-01-12 |
2013-12-17 |
The Trustees Of The University Of Pennsylvania |
Long-term delivery formulations and methods of use thereof
|
|
EP1576952A1
(en)
|
2004-03-18 |
2005-09-21 |
OctoPlus Technologies B.V. |
Hydrogel microspheres with improved release profile
|
|
NL1026261C2
(nl)
|
2004-05-25 |
2005-11-28 |
Nanomi B V |
Sproei inrichting met een nozzleplaat voorzien van structuren ter bevordering van self-breakup, een nozzleplaat, alsmede werkwijzen ter vervaardiging en toepassing van een dergelijke nozzleplaat.
|
|
US8236292B2
(en)
|
2004-06-04 |
2012-08-07 |
Camurus Ab |
Liquid depot formulations
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
WO2007139744A2
(en)
|
2006-05-23 |
2007-12-06 |
Titan Pharmaceuticals, Inc. |
Implantable polymeric device for sustained release of buprenorphine with minimal initial burst
|
|
US8206735B2
(en)
|
2006-07-11 |
2012-06-26 |
Foresee Pharmaceuticals, Llc |
Pharmaceutical compositions for sustained release delivery of peptides
|
|
FI20070174A0
(fi)
|
2007-02-28 |
2007-02-28 |
Delsitech Oy |
Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
|
|
KR100805208B1
(ko)
|
2007-03-27 |
2008-02-21 |
주식회사 펩트론 |
엑센딘 함유 서방성 제제 조성물, 엑센딘 함유 서방성미립구 및 이의 제조 방법
|
|
WO2008130158A1
(en)
|
2007-04-19 |
2008-10-30 |
Dong-A Pharmaceutical. Co., Ltd |
A biodegradable microsphere composition suitable for the controlled release of glucose controlling peptide and formulation thereof
|
|
ES2562878T3
(es)
|
2007-05-25 |
2016-03-08 |
Indivior Uk Limited |
Formulaciones de liberación sostenida de compuestos de risperidona
|
|
ES2324009B1
(es)
|
2007-11-23 |
2010-05-21 |
Gp Pharm S.A. |
Composicion farmaceutica de liberacion sostenida de somatostatina o un analogo suyo.
|
|
US20090181068A1
(en)
|
2008-01-14 |
2009-07-16 |
Dunn Richard L |
Low Viscosity Liquid Polymeric Delivery System
|
|
WO2009148580A2
(en)
|
2008-06-03 |
2009-12-10 |
Qlt Usa, Inc. |
Controlled release copolymer formulation with improved release kinetics
|
|
RU2504360C2
(ru)
|
2008-08-12 |
2014-01-20 |
Новартис Аг |
Фармацевтические композиции
|
|
PT2355853T
(pt)
|
2008-10-10 |
2017-03-15 |
Polyactiva Pty Ltd |
Conjugados polímero biodegradável ¿ unidade bioativa
|
|
JP2012512175A
(ja)
|
2008-12-15 |
2012-05-31 |
バインド バイオサイエンシズ インコーポレイテッド |
治療薬を徐放するための長時間循環性ナノ粒子
|
|
CA2792484C
(en)
|
2009-03-12 |
2017-10-31 |
Delpor, Inc. |
Implantable device for long-term delivery of drugs
|
|
AU2016228315B2
(en)
*
|
2009-09-17 |
2018-01-04 |
Bespoke Bioscience, Llc |
Role of n-2 hydroxy-ethyl-piperazine-n'-2-ethane sulfonic acid (hepes) in pain control and reversal of demyelinization injury
|
|
WO2011042453A1
(en)
|
2009-10-06 |
2011-04-14 |
Ascendis Pharma As |
Subcutaneous paliperidone composition
|
|
HUE060304T2
(hu)
|
2010-01-04 |
2023-02-28 |
Mapi Pharma Ltd |
Glatiramer acetátot tartalmazó depó rendszer
|
|
EP2343046A1
(en)
|
2010-01-08 |
2011-07-13 |
Nirvana's Tree House B.V. |
Functionalised triblock copolymers and compositions containing such polymers
|
|
PL2394663T3
(pl)
|
2010-05-31 |
2022-02-21 |
Laboratorios Farmaceuticos Rovi, S.A. |
Kompozycje do wstrzykiwania implantów biodegradowalnych in-situ
|
|
UA111162C2
(uk)
|
2010-08-04 |
2016-04-11 |
Флекшен Терап'Ютікс, Інк. |
Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
|
|
FR2968994B1
(fr)
|
2010-12-17 |
2012-12-28 |
Flamel Tech Sa |
Procede de preparation de nanoparticules
|
|
US9023897B2
(en)
|
2010-12-29 |
2015-05-05 |
Medincell |
Biodegradable drug delivery compositions
|
|
HRP20192276T1
(hr)
|
2011-06-10 |
2020-05-15 |
Ramscor, Inc. |
Formulacije s produljenim oslobađanjem za dostavu proteina u oko i postupci njihove pripreme
|
|
US20130144250A1
(en)
|
2011-10-24 |
2013-06-06 |
Endo Pharmaceuticals Solutions Inc. |
Implantable drug delivery compositions and methods of treatment thereof
|
|
BR112014017969A8
(pt)
|
2012-01-23 |
2017-07-11 |
Allergan Inc |
Microesferas ou micropartículas bioerodíveis ou bio-degradáveis liberadas por tempo suspensas em uma formulação de droga injetável de formação de depósito
|
|
US20140323517A1
(en)
|
2013-04-30 |
2014-10-30 |
Heron Therapeutics, Inc. |
Compositions and methods for injection of a biodegradable polymer-based delivery system
|
|
US9943484B2
(en)
|
2013-06-20 |
2018-04-17 |
Pharmathen S.A. |
Preparation of polylactide-polyglycolide microparticles having a sigmoidal release profile
|
|
CN111194312A
(zh)
*
|
2017-10-09 |
2020-05-22 |
提瓦制药工业公司 |
依地普仑的新盐和固态形式
|